SCHEMBL2447368

SCHEMBL2447368

O/N=C\c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPFFR1 Q9GZQ6 2/20 0.43
NPFFR2 Q9Y5X5 2/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HTT P42858 1/20 0.42
KIF11 P52732 2/20 0.38
APP P05067 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM4 Q14833 1/20 0.36
KMT2A Q03164 2/20 0.36
ACHE P22303 1/20 0.36
PKM P14618 1/20 0.36
MEN1 O00255 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
PLA2G7 Q13093 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2447369 1.00 NPFFR1 (0.43) NPFFR1NPFFR2ALDH1A1L3MBTL1KDM4E
SCHEMBL21236969 0.81 NPFFR1 (0.40) NPFFR1NPFFR2ALDH1A1L3MBTL1KIF11
SCHEMBL15611217 0.80 NPFFR2 (0.65) NPFFR1NPFFR2ALDH1A1L3MBTL1KDM4E
SCHEMBL16681061 0.80 NPFFR1 (0.42) NPFFR1NPFFR2ALDH1A1L3MBTL1KDM4E
SCHEMBL16681059 0.80 NPFFR1 (0.42) NPFFR1NPFFR2ALDH1A1L3MBTL1KDM4E
SCHEMBL15611218 0.80 NPFFR2 (0.65) NPFFR1NPFFR2ALDH1A1L3MBTL1KDM4E
SCHEMBL16993678 0.78 NPFFR2 (0.71) NPFFR1NPFFR2KMT2A
SCHEMBL2472098 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHTTNPC1
SCHEMBL2474936 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHTTNPC1
SCHEMBL2472101 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed